ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 173 filers reported holding ZAI LAB LTD in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $323,760 | -97.9% | 13,318 | -97.1% | 0.00% | -100.0% |
Q2 2023 | $15,242,992 | 0.0% | 458,298 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $15,242,992 | +19.3% | 458,298 | +10.1% | 0.01% | 0.0% |
Q4 2022 | $12,781,424 | -99.9% | 416,333 | -0.3% | 0.01% | -12.5% |
Q3 2022 | $14,276,892,000 | -0.9% | 417,453 | +0.5% | 0.01% | 0.0% |
Q2 2022 | $14,403,714,000 | -22.2% | 415,332 | -1.4% | 0.01% | 0.0% |
Q1 2022 | $18,525,035,000 | -32.1% | 421,215 | -3.0% | 0.01% | -20.0% |
Q4 2021 | $27,283,437,000 | -35.5% | 434,104 | +8.1% | 0.01% | -44.4% |
Q3 2021 | $42,329,366,000 | -37.6% | 401,645 | +4.8% | 0.02% | -37.9% |
Q2 2021 | $67,824,338,000 | +40.3% | 383,210 | +5.8% | 0.03% | +38.1% |
Q1 2021 | $48,340,088,000 | -0.6% | 362,288 | +0.8% | 0.02% | -8.7% |
Q4 2020 | $48,649,723,000 | +150.7% | 359,463 | +54.0% | 0.02% | +130.0% |
Q3 2020 | $19,407,803,000 | +49.5% | 233,351 | +47.6% | 0.01% | +25.0% |
Q2 2020 | $12,981,878,000 | +155.2% | 158,065 | +60.0% | 0.01% | +100.0% |
Q1 2020 | $5,086,224,000 | – | 98,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |